← All stories
Markets
Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference
CAMBRIDGE, Mass. — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that…
Covered by 1 outlet
All coverage · 1 article